Invention Grant
- Patent Title: Anti-human respiratory syncytial virus (RSV) antibodies and methods of use
-
Application No.: US14297486Application Date: 2014-06-05
-
Publication No.: US09403900B2Publication Date: 2016-08-02
- Inventor: Robert Anthony Williamson , Jehangir Wadia , Gabriel Pascual , Elissa Keogh
- Applicant: Crucell Holland B.V.
- Applicant Address: NL Leiden
- Assignee: Crucell Holland B.V.
- Current Assignee: Crucell Holland B.V.
- Current Assignee Address: NL Leiden
- Agency: TraskBritt, P.C.
- Main IPC: C07K16/10
- IPC: C07K16/10 ; G01N33/569 ; A61K39/42 ; C07K16/46 ; C12N7/00 ; A61K31/7056 ; A61K39/00
Abstract:
Provided herein are antibodies or antigen-binding fragments thereof that immunospecifically bind to the fusion (F) protein of Respiratory Syncytial Virus (RSV). Also provided are methods for of prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of RSV-mediated disease. Methods of generating antibodies that immunospecifically bind RSV F protein also are provided.
Public/Granted literature
- US20140363427A1 ANTI-HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIBODIES AND METHODS OF USE Public/Granted day:2014-12-11
Information query
